Ray Dalio Bio Rad Laboratories, Inc. Transaction History

Bridgewater Associates, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$269.37 - $365.04 $4.31 Million - $5.84 Million	-15,988 Reduced 95.4%	771 $248,000
Q3 2023 Nov 13, 2023	BUY	$350.25 - $422.63 $101,572 - $122,562	290 Added 1.76%	16,759 $6.01 Million
Q2 2023 Aug 11, 2023	BUY	$359.49 - $486.4 $5.63 Million - $7.62 Million	15,666 Added 1950.93%	16,469 $6.24 Million
Q1 2023 May 12, 2023	SELL	$418.69 - $503.0 $4.68 Million - $5.62 Million	-11,171 Reduced 93.29%	803 $384,000
Q4 2022 Feb 13, 2023	BUY	$351.71 - $456.01 $1.25 Million - $1.62 Million	3,563 Added 42.36%	11,974 $5.04 Million
Q3 2022 Nov 10, 2022	BUY	$412.59 - $563.26 $2.14 Million - $2.92 Million	5,178 Added 160.16%	8,411 $3.51 Million
Q2 2022 Aug 11, 2022	BUY	$463.67 - $597.16 $1.32 Million - $1.7 Million	2,848 Added 739.74%	3,233 $1.6 Million
Q1 2022 May 13, 2022	BUY	$524.57 - $735.42 $201,959 - $283,136	385 New	385 $217,000
Q1 2019 May 14, 2019	SELL	$224.3 - $317.41 $1.48 Million - $2.09 Million	-6,590 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$220.1 - $309.0 $1.01 Million - $1.41 Million	4,574 Added 226.88%	6,590 $1.53 Million
Q3 2018 Nov 13, 2018	BUY	$289.28 - $326.15 $53,227 - $60,011	184 Added 10.04%	2,016 $631,000
Q2 2018 Aug 13, 2018	SELL	$244.1 - $303.88 $433,765 - $539,994	-1,777 Reduced 49.24%	1,832 $0
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $3.66 Million - $4.29 Million	-15,646 Reduced 81.26%	3,609 $903,000
Q4 2017 Feb 13, 2018	BUY	$216.94 - $271.3 $4.18 Million - $5.22 Million	19,255	19,255 $4.6 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.